MelliCell develops technology that studies and uses fat cells to find new treatments for chronic diseases.
MelliCell's investors include LvlUp Ventures, National Science Foundation, National Institute of Diabetes and Digestive and Kidney Diseases.
MelliCell is headquartered in Newton, United States.
MelliCell develops technology that studies and uses fat cells to find new treatments for chronic diseases.
MelliCell is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"MelliCell — Funding & Investors." VCBacked, October 28, 2025, https://www.vcbacked.co/company/mellicell. Accessed September 30, 2026.
VCBacked. (2025). MelliCell — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/mellicell
{{cite web |title=MelliCell — Funding & Investors |url=https://www.vcbacked.co/company/mellicell |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated